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LETTERS TO THE EDITORRegarding “Giant-cell temporal arteritis in a
17-year-old male”
Pipinos et al1 have recently reported the case of temporal giant
cell arteritis (GCA) in a 17-year-old male (the fifth case in the
literature). This letter describes another case of GCA in a 28-year-
old man who presented to our outpatient clinic for a unilateral
nodule in the temporal region, which was slightly tender to palpa-
tion. The nodule (0.9 cm in diameter) was excised for cosmetic
reason and the diagnosis of classic GCA was made by histopatho-
logic analysis (Fig) that showed an artery with the adventitia
infiltrated with lymphocytes, the media and intima infiltrated with
histiocytes and multinucleated giant cells, eosinophils, and mono-
nuclears, and with areas of internal elastic lamina destruction.
Marked intimal hyperplasia was present and caused severe luminal
stenosis.
Because the histopathologic findings were indicative of GCA,
the patient was referred to an immunologist. The patient had a
history of allergic rhinitis. Two months before referral to outpa-
tient surgery clinic, the patient complained of headache and mal-
aise but failed to pay due attention to these discomforts, trying to
Fig. Arterial segment shows extensive intimal proliferatio
and media with predominant mononuclear cell infiltration (Mrelieve them by intermittent use of nonsteroid antirheumatic
drugs. The patient denied fever, visual impairments, or jaw claudi-
cation. On examination, only a minor postoperative wound was
found. Immunologic and laboratory test results, including eryth-
rocyte sedimentation rate andC-reactive protein, Doppler imaging
of carotid arteries, and brain magnetic resonance imaging were
normal.
The diagnosis of classic GCA was based on three of the five
criteria proposed by the American College of Rheumatology.2 The
patient was treated with corticosteroids for 1.5 years, in contrast to
Pipinos et al,1 who treated their patient for only 3 months. There
is no consensus on the optimal corticosteroid regimen for GCA;
however, most authors agree that corticosteroid therapy should be
administered for 1 to 2 years.3 Results of various studies suggest
that, despite good control of systemic symptoms with corticoste-
roids, a smoldering inflammatory disease remains that may later
lead to severe complications of the vascular wall such as aortic
aneurysms.3
Although GCA is not a thromboembolic disease, therapeutic
benefit has been reported with the low-dose aspirin, also used in
our patient.3
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Regarding “Proximalization of the arterial inflow:
a new technique to treat access-related ischemia”
Zanow et al1 have published an important series confirming
the role of proximalization of the arterial inflow (PAI) for
treatment of the steal syndrome. The operation they describe
does not, however, merit the designation “new” (as placed on
the Journal cover, the title, and in Dr Fillinger’s invited com-
mentary)— only its acronym. The authors acknowledge that Dr
Haimov and colleagues2 reported their serendipitous discovery
of the procedure in 1996, but they only speculated on how it
improves distal flow. I described a case with hemodynamic detail
in an article discussing a flow model for various steal treatments3
and commented there and elsewhere4,5 that I use it often to
prevent and treat steal syndromes in both the upper and lower
extremities. Others have also noted that the operation benefits
patients with steal.6 Furthermore, the operation is hemodynam-
ically identical to the distal revascularization interval ligation
(DRIL) procedure, a PAI variant in which the native artery
serves as the proximal half of the loop and the conduit used for
distal revascularization (DR) serves as the inflow for the distal
circulation. In that sense, hundreds of physicians have already
used PAI to treat a steal.
Dr Fillinger’s operation of distal revascularization without
interval ligation (DR without IL), also described previously,3-5 is
technically not PAI, but rather a direct way to improve down-
stream pressure. Nevertheless, all three operations share an impor-
tant clinical feature: namely, the more proximal the anastomosis,
the greater the relief of the steal. They differ in the role of conduit
size: the smaller the interposed conduit for PAI and the larger the
conduit for DR without IL, the more flow to the hand; conduit
size is not important in the DRIL procedure.
One other point warrants comment. The reason PAI and
DRIL work is not because the anastomosis is created on a larger
artery with more capacitance, but rather because, in the reconfig-
ured circuit, flow to the hand originates at a point with higher
pressure (or voltage, if one is using an electrical model).3 This
simple physiological truth suggests that the acronym PAI should
refer not only to the proximalization of the fistula’s origin, but also
to the origin of flow to the distal extremity, because both are
proximalized at the same time. Because the size of the inflow vessel
is immaterial to the success of PAI,3 I have never found it necessary
to proximalize an access to the proximal axillary artery. The distal
axillary artery has served nicely in each instance.Wayne S. Gradman, MD
Cedars-Sinai Medical Center
Beverly Hills, Calif
REFERENCES
1. Zanow J, Kruger U, Scholz H. Proximalization of the arterial inflow: a
new technique to treat access-related ischemia. J Vasc Surg 2006;43:
1216-21.
2. Haimov M, Schanzer H, Skladani M. Pathogenesis and management of
upper-extremity ischemia following angioaccess surgery. Blood Purif 1996:
14:350-4.
3. Gradman WS, Pozrikidis C. Analysis of options for mitigating hemodi-
alysis access-related ischemic steal phenomena. Ann Vasc Surg 2004;18:
59-65.
4. Gradman WS, Cohen W, Haji-Aghaii M. Arteriovenous fistula construc-
tion in the thigh with transposed superficial femoral vein: our initial
experience. J Vasc Surg 2001;33:968-75.
5. Knox RC, Berman SS, Hughes JD, Gentile AT, Mills JL. Distal
revascularization-interval ligation: a durable and effective treatment
for ischemic steal syndrome after hemodialysis access. J Vasc Surg
2002;36:250-5; discussion 256.
6. Barone GW, Lightfoot MM, Kumar GV, Eidt JF. Loop-configured upper-
arm hemodialysis graft for the “hostile” arm. J Am Coll Surg 2003;197:
1053-5.
doi:10.1016/j.jvs.2006.07.050
Reply
I respectfully submit that the article by Zanow et al merits
the designation “new.” They have reported the first large series
with the proximilization of arterial inflow (PAI) procedure,
encompassing 30 patients with documentation of mean flow,
digital pressures, and clinical outcomes for multiple different
access combinations over a mean follow-up of 26 months. The
references provided in the letter to the editor include some
innovative work with lower extremity access, banding, and a
very nice theoretical construct expanding on a similar “electrical
circuit” model initially described by David Sumner in 1975.
Despite this, the primary reference to the PAI-type proce-
dure in the letter (Gradman WS, Pozrikidis C. Ann Vasc Surg
2004;18:59-65) is a theoretical construct and the anecdotal
report of a single clinical case with no follow-up. The references
to other authors are for distal revascularization-interval ligation
(DRIL) reports and anecdotal comments on those reports with
no data provided. Thus, the report by Zanow et al is novel and
provides enough clinical information to incorporate into clinical
decision-making.
Regarding other comments, I do not believe the PAI
procedure is “hemodynamically identical to the DRIL proce-
dure.” Yes, there are hemodynamic similarities, as pointed out
in my commentary, but they are clinically quite different, as
there is no arterial ligation, which is the point of the report.
With regard to “distal revascularization without interval liga-
tion,” I made no attempt to state that I invented the procedure.
I only used it to point out similarities in the hemodynamic
concept for an operation I have personally used.
Finally, the hemodynamic explanation in my commentary is
consistent with the “electrical circuit” model for steal. The
letter states “. . . in the reconfigured circuit, flow to the hand
originates at a point with higher pressure.” While a somewhat
confusing way to describe it, flow to the hand could not
“originate at a point with higher pressure” unless there was less
pressure drop across the proximal anastomosis, and this requires
a larger inflow artery better capable of handling the flow, as
described in the commentary.
